| 1st Author (year) |
# Patients Treated |
Max GK Dose (Gy) |
Period of Follow-Up |
Tremor Improvement Rate |
Patient Complications |
Complication Rate |
| Kondziolka [5] |
31 |
130-140 |
Median: 36 months |
92% |
hemiparesis, dysphagia, dysarthria |
7.7% |
| Young [6] |
161 |
141-152 |
Mean: 44 ± 33 months |
Drawing: 81% Writing: 77% |
sensory loss, motor impairments, dysarthria |
8.4% |
| Duma [7] |
38 |
120-160 |
Median: 30 months |
90% |
dysarthria |
2.6% |
| Young [8] |
PD: 102 ET: 52 |
120-160 |
<12-96 months |
PD: 88.3% ET: 92.1% |
balance disturbance, paresthesias, weakness, dysphagia |
1.3% |
| Ohye [9] |
53 |
130 |
24 months |
81.1% |
transient slight motor weakness |
1.9% |
| Mathieu [10] |
6 |
130-150 |
Median: 27.5 months |
100% |
hemiparesis |
16.7% |
| Niranjan [11] |
11 |
130-150 |
Median: 6 months |
100% |
dysarthria, weakness |
9.1% |
| Niranjan [12] |
12 |
130-150 |
Median: 24 months |
100% |
dysarthria, weakness |
8.3% |
ET = essential tremor; PD = Parkinson’s disease |
